Twist Bioscience Corp (FRA:0ME)
€ 39.22 -1.36 (-3.35%) Market Cap: 2.23 Bil Enterprise Value: 2.04 Bil PE Ratio: 0 PB Ratio: 4.90 GF Score: 83/100

Twist Bioscience Corp at Goldman Sachs Global Healthcare Conference (Virtual) Transcript

Jun 08, 2021 / 07:50PM GMT
Release Date Price: €81.86 (+5.49%)
Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst

Welcome everybody. I am Matt Sykes, the senior life sciences tools and diagnostic analyst at Goldman Sachs. And today we have the pleasure of welcoming Twist Biosciences to our conference. I want to introduce Emily Leproust, the Chief Executive Officer; Jim Thorburn, Chief Financial Officer; and Angela Bitting, the Head of Investor Relations. Emily, Jim, Angela, thank you very much for joining us. We're happy to have you here.

Maybe I thought we just -- Thank you. Maybe I thought we'd just start out and kind of set -- turn it over to you to set the stage a little bit and maybe talk about some of your -- the recent quarter, some of your views on the year and just kind of set the stage for us to start out.

Emily Marine Leproust
Twist Bioscience Corporation - Co-Founder, Chairman, President & CEO

Great. thank you. So I'll share my screen, so I can show a few slides. For those of you who don't know Twist, of course, I'll make some forward-looking statement. But

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot